Period of Performance:
- Expected Start Date (on or about): January 22, 2018 (or sooner, if possible)
- Anticipated End Date (on or about): March 31, 2018
- The period of performance could possibly be extended to continue to provide technical assistance to program beyond March 31, 2018 depending on consultant performance and program need.
Location: Southern Africa (with program centered in Mbabane, Swaziland)
Objectives: Baylor-Malawi is seeking a consultant experienced in the areas of pharmacy systems strengthening and pharmaceutical supply chain management to support the transition of the SIAPS (Systems for Improved Access to Pharmaceuticals and Services) program in Swaziland from Management Sciences for Health (MSH) to Baylor-Malawi and the TSP program.
The transition period during which Baylor-Malawi and its TSP consortium partner, Baylor College of Medicine Children’s Foundation Swaziland (Baylor-Swaziland), will be preparing to continue SIAPS program work and set-up a new program recently started in mid-December and will run through March 22, 2018.On that date, the TSP Program will be responsible for the National Program, which will encompass pharmaceutical systems support, regulation for safety and efficacy and supply chain management.
Baylor-Malawi and the TSP program require a consultant experienced in the areas of pharmacy systems strengthening and pharmaceutical supply chain management to provide technical assistance and advisory services to support Baylor-Malawi and Baylor-Swaziland during the transition period. The consultant’s support will facilitate a smooth transition of the existing program and staff, help identify and select key personnel to lead the program going forward, provide technical inputs and support on longer-term work plans to support stakeholder needs, and ensure adequate technical support is provided to the local staff in the short-term and on an ongoing basis.
About the Organization
Background: Baylor College of Medicine Children’s Foundation Malawi is a not-for-profit organization partnering with the Government of Swaziland in the health sector. The mission is to improve the health and lives of HIV-infected children and families through high quality, high impact, ethical, state-of-the-art, comprehensive care and treatment, training of health professionals, and clinical research. Baylor-Malawi has an international reputation for innovative, evidence-based HIV service delivery programming.
In 2016, USAID signed a cooperative agreement with Baylor-Malawi for the Technical Support to PEPFAR Programs in the Southern Africa Region—or TSP—Program to reduce the impact of HIV/AIDS in ten countries: Angola, Botswana, Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Zambia, and Zimbabwe. As part of the TSP program, focal countries will be supported to reach ambitious UNAIDS 90-90-90 goals: 90% of HIV-infected individuals know their status; 90% of patients who know their status adhere to anti-retroviral therapy (ART); and 90% of patients on ART are virally suppressed by 2020. Baylor-Swaziland is a member of the TSP Consortium that includes Baylor-Malawi and other Baylor partners throughout Southern Africa.
Through TSP, Baylor-Malawi and its partners like Baylor-Swaziland provide technical assistance to regional HIV/AIDS programs and build the capacity of country teams to eventually take full ownership of the programs. Assistance includes technical expertise, human resource capacity, physical infrastructure, program implementation experience, and regional coordination and communication with a special focus on women, children, and adolescents with HIV.
Through the TSP Program, Baylor-Malawi and Baylor-Swaziland are partners in absorbing and continuing the SIAPS (Systems for Improved Access to Pharmaceuticals and Services) program in Swaziland.
The goal of the new program will be similar to that of SIAPS – to improve the delivery and consistent use of HIV, TB and other reproductive health commodities and essential pharmaceutical services to achieve desired HIV, TB and reproductive health outcomes. The program will take a systems-wide approach to meet sustainable disease-specific objectives through two main intermediate results:
- Building organizational capacity for pharmaceutical management at the regional, facility and community level through a diversified network of distribution channels; and
- Strengthening central level decision-making using strategic information systems and technology to improve HIV and TB treatment procurement, warehousing and logistics.
To these ends, the program will also provide support for strengthening national regulatory safety and quality assurance of the drug supply system as well as preventing and detecting antimicrobial resistance.